In this week’s Video Forum, Dr. Vin Gupta, Amazon Pharmacy’s chief medical officer, talks about the potential for e-commerce providers to help bring down the cost of prescription medications. In addition to outlining various ways in which Amazon is trying to do just that, Gupta responds to those who contend that online pharmacies can’t provide the same level of service as their brick-and-mortar counterparts, as well as discussing Amazon’s intention to play a bigger role in American health care going forward.
Video Forum: Vin Gupta, Amazon Pharmacy
In this week’s Video Forum, Dr. Vin Gupta, Amazon Pharmacy’s chief medical officer, talks about the potential for e-commerce providers to help bring down the cost of prescription medications.
Related
Kroger-Albertsons merger goes on trial in an Oregon federal court
The FTC faces off against lawyers from Albertsons and Kroger in a fight over competition in the grocery channel.
FDA approves Moderna’s updated COVID-19 vaccine
Moderna's updated COVID-19 vaccine targets the KP.2 variant of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older.
Kroger sues FTC, claims merger challenge violates Constitution
The company argues that by proceeding in its administrative tribunal, in addition to the separate action in federal court, the FTC is violating Constitutional protections.
CRN to Federal Appeals Court: NY AG’s arguments don’t support denial of preliminary injunction in NY age restrictions case
CRN’s most recent brief argues that the NY AG does not meaningfully address CRN’s arguments about the Act’s constitutional infirmities.
Latest
Senate finance leaders introduce bipartisan PBM Reform, NACDS hails move and calls for swift passage
Legislation aims to curtail harmful PBM middlemen tactics that inflate drug costs and force pharmacies to close.
NCPA urges Congress to pass Crapo-Wyden PBM Reforms
Wide bipartisan support means no more excuses, says NCPA.
Kroger Q3 earnings beat estimates
Gains in eCommerce and private-label brands offset charges tied to automated fulfillment network; grocer lifts earnings guidance for the year.
CVS Health to pay $37.76 million over insulin pen overbilling allegations
Settlement resolves decade-long False Claims Act violations tied to premature refills and inaccurate reporting to federal health care programs.